S. 1062 · 115th Congress
FDA Reporting Transparency and Accountability Act
- Stage
- In committee
- Sponsor
- Richard Burr
- Introduced
- 2017-05-04
- Latest action
- 2017-05-04 · Introduced in Senate
Summary
FDA Reporting Transparency and Accountability Act
This bill expands reporting requirements related to the performance of the Food and Drug Administration (FDA), including to require additional information on timeliness and personnel and publication every 30 days of information regarding FDA guidance and meetings.